{
  "schema_version": "1.3.1",
  "doc": {
    "doc_id": "17b228426521d048b9fa776c44fe353d",
    "title": "Jefferies",
    "source_uri": "25.9月 普通个人版/9.1 普通个人版/Jefferies/2Q Sales Beat 12 F1 Installs HIFU Vols 5 Raised HIFU Guide 1.80 PT2Q Sales Beat 12 F1 Installs HIFU Vols 5 Raised HIFU G_2025-08-28",
    "language": "en",
    "timestamps": {
      "ingested_at": "2025-10-26T12:16:26.996184",
      "extracted_at": "2025-10-26T12:16:26.996199"
    },
    "extraction_run": {
      "vision_model": "deepseek-ai/DeepSeek-OCR",
      "synthesis_model": "rule-based-engine",
      "pipeline_steps": [
        "ocr",
        "rule_extraction",
        "figure_vision"
      ],
      "processing_metadata": {
        "pages_processed": 10,
        "successful_pages": 10,
        "date": "2025-08-28",
        "publication": "25.9月 普通个人版/9.1 普通个人版/Jefferies",
        "authors": [],
        "markdown_cleaning": {
          "removed_sections": 2,
          "removed_paragraphs": 10,
          "reduction_ratio": 0.22470620736553537
        },
        "input_relative_path": "25.9月 普通个人版/9.1 普通个人版/Jefferies"
      }
    }
  },
  "passages": [
    {
      "passage_id": "e0b021f7f33f83a5",
      "text": "USA | Medical Supplies & Devices",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "e09fa8bc5386ddfb",
      "text": "2Q Sales Beat; (+)12 F installs; HIFU Vols +5%;Raised HIFU Guide; &#36;100 PT",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "039fb3044cc02ffd",
      "text": "2Q sales increased 9% and beat cons driven by a healthy 12 Focal One placements (&lt;cons). US HIFU procedure growth of ~5% remained subdued on payer pushback but EDAP noted some improvement here. No chg to capEx environment. EDAP disclosed a EUR 36MM credit facility LOI, which we think reduces equity raise risk. EDAP raised its FY25 HIFU sales growth guide to +26-34% on higher system sales. We raise estimates on the 2Q beat and raise PT to &#36;1.80. Reit. Hold.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "a7da01c82c94ad6e",
      "text": "**2Q sales of ~&#36;18MM (EUR 16MM), -9% y/y, were above cons &#36;16MM. HIFU sales of EUR 8.5MM** grew 77% y/y on higher Focal One units sold y/y, +24% disposables growth, and HIFU procedure growth grew 5% (vs 4% prior qtr). Sales in non-core Litho/Distribution of EUR 7.6MM declined 31% y/y, an expected decline as EDAP strategically de-emphasizes the biz. Operating loss was EUR 5.8MM vs 6MM loss in 1Q25. **EDAP expects a 15% tariff impact on all goods transferred from France to the US. We estimate this could equate to &#36;350-450k/qtr in 2H.**",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "4129ca46f219f39b",
      "text": "2Q cash burn of USD ~&#36;6.4MM was effectively unchanged vs &#36;6.7MM in 1Q25, EDAP had ~&#36;19MM cash at 6/30. **EDAP expects cont'd HIFU investment and disclosed a letter of intent (still finalizing terms) for EUR 36MM (USD &#36;42MM) credit facility, which we view as favorable given it lowers the risk of a dilutive equity raise near term.** EDAP is commencing a controlled endometriosis launch in several Europe markets and expects to commence a US BPH clin trial in early 2026.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "8bf1588972ffa91a",
      "text": "**HIFU sales of EUR 8.5MM, +77% y/y, incl 12 Focal One systems placed in 2Q, &gt; JeffE's 5 system forecast. 2Q placements incl 9 capital sales, 3 op leases; up from 3 capital sales in 2Q24.** EDAP now has multiple accounts who have purchased a second system incl Hackensack Meridian,Baptist Health, and NY Presbyterian. Focal One i launch is ongoing w/ mgmt noting several cases have been performed on the new system.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "f5d221dee0c22a3a",
      "text": "**US HIFU procedure growth ~5% y/y, a slight acceleration vs +4% y/y in 1Q25 but down vs** **+33% y/y in 4Q24 w/ EDAP again calling out longer, more challenging payor reviews/approval** **processes, partic for Medicare Advantage pts. EDAP noted it is beginning to see some improvement** on this front as the co works with market access partners to accelerate pre-authorizations. 2Q HIFU disposables sales grew 24% y/y.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "9d178c7c35c49fb2",
      "text": "EDAP raised its FY guidance for HIFU sales growth to 26-34% vs 16-25% prior and reduced its guidance for the non-core ESWL and Distribution businesses now expecting a FY25 decline of 25-30% vs 20-25% prior. **EDAP's higher HIFU growth outlook reflects stronger systems sales,higher services revs, part offset by lower disposables growth.**",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "ecea5387d1d9cf71",
      "text": "**We raise our sales forecast on the 2Q beat. We raise PT to &#36;1.80, which is based on 0.5-1x our** sales. Our prior PT was based on ~0.5-1x sales.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "0e111d096efec34d",
      "text": "FY (Dec)2023A2024A2025E2026ECons. Rev.63.269.272.273.5Rev. (MM)65.469.067.060.3Cons. EPS(0.54)(0.55)(0.58)(0.44)EPS(0.62)(0.55)(0.79)(0.77)",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "8c1bf39db37a4126",
      "text": "Equity ResearchAugust 28,2025",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "414bde7ac31f6d89",
      "text": "TARGET | ESTIMATE CHANGERATINGHOLDPRICE&#36;1.58*PRICE TARGET | % TO PT&#36;1.80 (&#36;1.75) | +14%52W HIGH-LOW&#36;3.77 - &#36;1.21FLOAT (%) | ADV MM (USD)0.0% | 0.12MARKET CAP&#36;59.1MTICKEREDAP",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "4201e6a2c98c6fab",
      "text": "*Prior trading day's closing price unless otherwise noted.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "cc45b74db1f7dbe1",
      "text": "FY (Dec)CHANGE TO JEFeJEF vs CONS2025202620252026REV+9%+2%-7%-18%EPS+7%+10%-36%-77%",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "56fc78bd91ca635d",
      "text": "EPS(0.20)(+0.17)(+0.23)(+0.18)(+0.79)PREV(0.21)(0.24)(0.20)(0.85)",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "034748882c4fbdc6",
      "text": "**Matthew Taylor, CFA * | Equity Analyst**",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "fe8a7f4265ce55bc",
      "text": "**Young Li * | Equity Analyst**",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "30399df568188d7c",
      "text": "**Michael Toomey, CFA * | Equity Analyst**",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "3ec77b82a7356790",
      "text": "**Matthew Aspro * | Equity Associate**",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "b3453e726ce15eeb",
      "text": "We expect EDAP to continue to make progress driving Focal One HIFU penetration in PCa and also to have several pipeline opportunities. That said, we think consensus estimates are too high both in HIFU and on a consolidated basis. Moreover, we think the exit of Litho system sales and some distribution geographies will likely weigh on corporate sales growth through FY26. We await regulatory clarity on EDAP's endometriosis oppy, which cold represent upside to our #s. We view the risk/reward for shares as balanced. Our PT of \\(\\) 1.80\\(is based on \\~1x our 26E sales.\\)",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "20fd438043f8c237",
      "text": "Risk/Reward - 12 Month View",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "d2106d23265570a9",
      "text": "Our base- case PT of \\(\\) 1.80\\(is based on \\~0.5 - 1x EV/ sales on 2026E sales of\\) \\ \\(60MM\\)",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "13da46610963e2f9",
      "text": "We forecast a 3- year sales CAGR of - 4%, which includes HIFU prostate procedure volume growth in the US.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "620ab217fde2d90d",
      "text": "Our PT assumes the multiple holds steady.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "26b383fb18ae15b9",
      "text": "Our upside scenario PT of \\(\\) 2.50\\(is based on a\\) \\sim 1x \\(EV/sales multiple on our 2026 upside sales estimate of\\) \\ \\(66MM\\)",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "6e6c714c49fbc2b0",
      "text": "We forecast a 3 year sales CAGR of \\(0\\%\\) which includes a significant acceleration in US HIFU prostate procedures and system placements.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "66680cc5e6f3a289",
      "text": "Our PT assumes a \\(\\sim 0.5x\\) turn multiple expansion, driven by accelerating HIFU adoption and system placements.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "0515822cf6312f44",
      "text": "Our downside scenario PT of \\(\\) 1.50\\(is based on a\\) \\sim 0.5x \\(EV/sales multiple on our 2026 sales estimate of\\) \\ \\(54MM\\)",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "f5cef01071277bda",
      "text": "We forecast a 3 year sales CAGR of - 7%, which includes a modest pace of HIFU prostate procedure adoption and a slowdown in US system placements.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "ded47817bda5a496",
      "text": "Our PT assumes the multiple contracts by 0- 0.5x turns.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "87bc38805bcf9779",
      "text": "Top Material Issues: 1) Supply Chain Mgmt - Uncertain global climate change could result in more intense and more frequent natural disasters, including but not limited to hurricanes, wildfires, and flooding. Such extreme disasters could pose risks to the company's facilities and disrupt their supply chain, causing them to incur additional operational costs. Most of EDAP's manufacturing takes place in a single facility near Lyon, France. 2) Mgmt of the Legal & Regulatory Environment - Climate change could result in new regulatory or legal obligations. Such new obligations could increase compliance costs to meet the regulatory or legal requirements and may adversely affect sourcing, manufacturing operations, and the distribution of products.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "61df1dc0916da1f3",
      "text": "Qs to Mgmt: 1) Do you have a contingency or redundancy plans in place in case of supply chain disruptions? 2) What preparations have you made to efficiently respond to potential changes in the regulatory environment to minimize financial impacts? 3) Do you plan to establish ESG goals? If not, why not?",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "b9f3cdca0cf56f0f",
      "text": "Link to ESG MedTech Framework",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "bf6d2e82fc8051b1",
      "text": "Focal One HIFU adoption: HIFU treatment penetration for PCa tissue ablation remains low in the US. Continued adoption could be a share catalyst.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "506347cd222f41cd",
      "text": "Quarterly results (ongoing): Quarterly updates on HIFU sales growth and Focal One system placements could be a share catalyst.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "e3185959ba01fb66",
      "text": "Color on US regulatory pathway for deep infiltrating endometriosis (mid- 25 to 2H25)",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "f218cfa8afa7a837",
      "text": "**FY25 Guidance: Raised HIFU Sales Growth Guidance 26-34% on Stronger System Placements; Non-**Core Biz to Decline 25-30%",
      "page": 2,
      "section": null
    },
    {
      "passage_id": "b6cadca1b56aaa3f",
      "text": "EDAP raised its FY25 guidance for HIFU growth to 26-34% vs 16-25% prior and reduced its guidance for the non-core ESWL and Distribution businesses now expecting a FY25 decline of 25-30%vs 20-25% prior. **EDAP's higher HIFU growth outlook reflects stronger systems sales, higher services** **revs, part offset by lower disposables growth.**",
      "page": 2,
      "section": null
    },
    {
      "passage_id": "9f178c93b01364a4",
      "text": "Exhibit 1 - EDAP FY25 Guidance",
      "page": 2,
      "section": null
    },
    {
      "passage_id": "ac0a1fd632bbcd00",
      "text": "2025 GuidanceNon-GAAP, $MM except p/s3/27/255/15/258/28/25CommentsLowMidHighLowMidHighLowMidHighTotal Sales (USD)&#36;64&#36;66&#36;69&#36;64&#36;66&#36;69 &#36;66&#36;68&#36;70% Reported growth-8%-4%-1%-8%-4%-1%-5%-2%2%Avg USD/EUR FX Rate1.101.101.101.101. 101.101.131.131.13Total Sales (EUR)&#36;57.9&#36;59.9&#36;62.0&#36;57.9&#36;59.9&#32;62.0&#36;58.2&#36;60.2&#36;62.2% Reported growth-10%-7%-3%-10%-7%-3%-9%-6%-3%HIFU sales (EUR)&#36;27.7&#36;28.7&#36;29.8&#36;27.7&#36;28.7&#29.8&#30.0&#31.0&#31.9% Reported Growth16%21%25%16%21%25%26%30%34%26-34% y/y sales growthESWL (Lithotripsy) Sales (EUR)&#36;6.7&#36;7.0&#36;7.2&#36;6.7&#36;7.0&#32.7&#36;6.3&#36;6.5&#36;6.7% Reported Growth-25%-23%-20%-25%-23%-20%-30%-28%-25%25-30% y/y sales declineDistribution sales (EUR)&#36;23.5&#36;24.3&#36;25.0&#36;23.5&#36;24.3&#35.0&#32.9&#32.7&#35.5% Reported Growth-25%-23%-20%-25%-23%-20%-30%-28%-25%25-30% y/y sales decline",
      "page": 2,
      "section": null
    },
    {
      "passage_id": "a3127baf0fb6e7a0",
      "text": "Source: Company reports and conference call commentary, Jefferies Research",
      "page": 2,
      "section": null
    },
    {
      "passage_id": "648612cb3caf10c2",
      "text": "Exhibit 2-EDAP Income Statement",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "507f206641f0f680",
      "text": "FY End Dec 312022A2023A2024A1Q25A2Q25A3Q25E4Q25E2025E2026E2027E$Mil, except p/s31-Dec31-Dec31-Dec31-Mar30-Jun30-Sep31-Dec31-Dec31-Dec31-DecNet Sales$58.0$65.4$69.0$14.3$18.4$14.9$19.4$67.0$60.3$62.5% growth11.6%12.9%5.5%-11.4%8.6%3.1%-9.6%-2.9%-10.0%3.7%Cost of sales$32.5$39.0$40.5$8.3$10.6$9.1$11.5$39.4$34.4$33.8Gross Profit$25.5$26.4$28.6$6.0$7.8$5.8$8.0$27.6$25.9$28.8% of sales43.9%40.4%41.4%42.0%42.5%39.0%41.0%41.2%43.0%46.0%SG&amp;amp;A$24.6$40.3$42.4$9.7$11.9$12.6$12.6$46.9$46.4$47.2% of sales42.5%61.6%61.5%68.1%64.7%85.0%65.0%70.0%77.0%75.5%% growth26%64%5%-2%11%24%9%11%-1.1%1.7%R&amp;amp;D$5.2$7.5$8.3$2.6$2.5$2.5$2.7$10.4$9.3$9.4% of sales8.9%11.5%12.1%18.1%13.8%17.0%14.0%15.5%15.5%15.0%% growth29%46%10%16%14%34%38%24%-10%0%Total Operating Expenses$29.8$47.9$50.8$12.3$14.5$15.2$15.4$57.3$55.8$56.6% of sales51.4%73.2%73.6%86.2%78.5%102.0%79.0%85.5%92.5%90.5%% growth26%61%6%2%12%25%13%13%-3%1%Operating Income/(Loss)($4.3)($21.4)($22.2)($6.3)($6.6)($9.4)($7.4)($29.7)($29.8)($27.8)Operating Margin %-7.5%-32.8%-32.2%-44.2%-36.0%-63.0%-38.0%-44.3%-49.5%-44.5%D&amp;amp;A$1.7$2.1$2.8$0.6$0.7$0.6$0.8$2.7$2.4$2.5% of sales2.9%3.2%4.0%4.0%4.0%4.0%-4.0%4.0%4.0%4%EBITDA($3)($19)($19)($6)($6)($9)($7)($27)($27)($25)% of sales-4.6%-29.6%-28.1%-40.2%-32.0%-59.0%-34.0%-40.3%-45.5%-40.5%Other (income) / expenseTotal Other (Income)/Expense(2.3)0.8(1.9)1.0(0.3)(0.5)(0.5)(0.2)(0.2)(0.2)Pre-tax Income/(Loss)($2.1)($22.2)($20.3)($7.3)($6.3)($8.9)($6.9)($29.5)($29.6)($27.6)Pre-Tax Margin-4%-34%-29%-51%-34%-60%-36%-44%-49%-44%Taxes$0.8$0.7$0.3$0.1$0.1$0.0$0.0$0.3$0.0($5.5)Tax Rate-40.6%-3.1%-1.5%-2.0%-1.7%0.0%0.0%-0.9%0.0%20.0%GAAP Net Income/(Loss)($2.9)($22.9)($20.6)($7.5)($6.4)($8.9)($6.9)($29.7)($29.6)($22.1)Avg diluted shares34.637.037.237.437.437.938.437.838.338.8GAAP EPS($0.07)($0.62)($0.55)($0.20)($0.17)($0.23)($0.18)($0.79)($0.77)($0.57)% growth-375%745%NMNMNMNMNMNMNM",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "6d8304b65a6bf5a1",
      "text": "Source: Company reports and filings; Jefferies",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "99f49732c62fee1f",
      "text": "Exhibit 3 -EDAP Revenue Build",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "ef0d4bb165d09d49",
      "text": "FY End Dec 312022A2023A2024A1Q25A2Q25A3Q25E4Q25E2025E2026E2027E$Mil consolidated sales31-Dec31-Dec31-Dec31-Mar30-Jun30-Sep31-Dec31-Dec31-Dec31-DecTotal Sales ($US)$58.0$65.5$69.2$14.3$18.3$14.9$19.4$66.9$60.3$62.5% growth y/y11.6%13.1%5.6%-11.4%7.9%2.9%-10.1%-3.3%-9.9%3.7%% comp adj growth y/y10.1%12.3%9.3%-5.1%8.6%8.4%-4.5%1.1%-6.6%-3.1%$ growth y/y$6$8$4($2)$1$0($2)($2)($7)$2$ growth q/q($7)$4($3)$5",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "87e8095dc2db4cd5",
      "text": "Source: Company reports and filings; Jefferies",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "83a7de1019d795d7",
      "text": "EDAP TMSEDAP TMS develops, commercializes, and distributes minimally invasive devices that use ultrasound technology for the diagnosis and treatment of various pathologies, including prostate cancer and urinary stones.",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "0cbd2156ea64c44c",
      "text": "Our PT of \\(\\) 1.80\\(is based on\\) \\sim 0.5 - 1x \\(EV/sales on 2026E sales. Upside risks to our PT include better than expected Focal One system placements and HIFU procedure uptake, earlier than expected regulatory clearance and commercialization of HIFU in deep infiltrating endometriosis and BPH. Downside risks to our price target include adverse impacts from the recently implemented 20% tariff on the EU, adverse reimbursement decisions, regulatory delays, competition, and macro headwinds.",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "43de16204cb99813",
      "text": "(Article 3(1)e and Article 7 of MAR) Recommendation Published Recommendation Distributed",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "64b2191ad2be4345",
      "text": "August 28, 2025 11:38 A.M. August 28, 2025 11:38 A.M.",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "a1ae7d48cd80644d",
      "text": "Buy - Describes securities that we expect to provide a total return (price appreciation plus yield) of \\(15\\%\\) or more within a 12- month period. Hold - Describes securities that we expect to provide a total return (price appreciation plus yield) of plus \\(15\\%\\) or minus \\(10\\%\\) within a 12- month period. Underperform - Describes securities that we expect to provide a total return (price appreciation plus yield) of minus \\(10\\%\\) or less within a 12- month period. The expected total return (price appreciation plus yield) for Buy rated securities with an average security price consistently below \\(10\\) is \\(20\\%\\) or more within a 12- month period as these companies are typically more volatile than the overall stock market. For Hold rated securities with an average security price consistently below \\(10\\) , the expected total return (price appreciation plus yield) is plus or minus \\(20\\%\\) within a 12- month period. For Underperform rated securities with an average security price consistently below \\(10\\) , the expected total return (price appreciation plus yield) is minus \\(20\\%\\) or less within a 12- month period. NR - The investment rating and price target have been temporarily suspended. Such suspensions are in compliance with applicable regulations and/or Jefferies policies.",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "0b1aa7d2c782fdc0",
      "text": "CS - Coverage Suspended. Jefferies has suspended coverage of this company. NC - Not covered. Jefferies does not cover this company.",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "54a37a2c69753f9b",
      "text": "Restricted - Describes issuers where, in conjunction with Jefferies engagement in certain transactions, company policy or applicable securities regulations prohibit certain types of communications, including investment recommendations.",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "bdce86e96b3dba7d",
      "text": "Monitor - Describes securities whose company fundamentals and financials are being monitored, and for which no financial projections or opinions on the investment merits of the company are provided.",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "9b2a0d27d9ee432b",
      "text": "Jefferies methodology for assigning ratings may include the following: market capitalization, maturity, growth/value, volatility and expected total return over the next 12 months. The price targets are based on several methodologies, which may include, but are not restricted to, analyses of market risk, growth rate, revenue stream, discounted cash flow (DCF), EBITDA, EPS, cash flow (CF), free cash flow (FCF), EV/EBITDA, P/E, PE/growth, P/C, P/FCF, premium (discount)/average group EV/EBITDA, premium (discount)/average group P/E, sum of the parts, net asset value, dividend returns, and return on equity (ROE) over the next 12 months.",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "016c68db015b57cc",
      "text": "Jefferies Franchise Picks include stock selections from among the best stock ideas from our equity analysts over a 12 month period. Stock selection is based on fundamental analysis and may take into account other factors such as analyst conviction, differentiated analysis, a favorable risk/reward ratio and investment themes that Jefferies analysts are recommending. Jefferies Franchise Picks will include only Buy rated stocks and the number can vary depending on analyst recommendations for inclusion. Stocks will be added as new opportunities arise and removed when the reason for inclusion changes, the stock has met its desired return, if it is no longer rated Buy and/or if it triggers a stop loss. Stocks having 120 day volatility in the bottom quartile of S&P stocks will continue to have a 15% stop loss, and the remainder will have a 20% stop. Franchise Picks are not intended to represent a recommended portfolio of stocks and is not sector based, but we may note where we believe a Pick falls within an investment style such as growth or value.",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "37a8b4ead26be211",
      "text": "- EADP TMS (EDAP: \\(1.58, HOLD)\\)",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "f83e961d1ea6a327",
      "text": "**Notes**: Each box in the Rating and Price Target History chart above represents actions over the past three years in which an analyst initiated on a company,made a change to a rating or price target of a company or discontinued coverage of a company.",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "51504ae283388ef7",
      "text": "I: Initiating Coverage",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "8854c75c589ea739",
      "text": "Distribution of RatingsIB Serv./Past12 Mos.JIL Mkt Serv./Past12 Mos.CountPercentCountPercentCountPercentBUY211260.69%36717.38%1175.54%HOLD121134.80%1058.67%221.82%UNDERPERFORM1574.51%31.91%31.91%",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "dc284418849cd4bc",
      "text": "Jefferies does busines and seeks to do busines with companies covered in its research reports, and expects to receive or intends to seek compensation for investment banking services among other activities from such companies. As a result, investors should be aware that Jefferies may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision.",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "5d9471c0c46fe235",
      "text": "Jefferies Equity Research refers to research reports produced by analysts employed by one of the following Jefferies Financial Group Inc. (Jefferies) companies: United States: Jefferies LLC which is an SEC registered broker- dealer and a member of FINRA (and distributed by Jefferies Research Services, LLC, an SEC registered Investment Adviser, to clients paying separately for such research).",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "89e1bd6f8f2380aa",
      "text": "Canada: Jefferies Securities Inc., which is an investment dealer registered in each of the thirteen Canadian jurisdictions and a dealer member of the Canadian Investment Regulatory Organization, including research reports produced jointly by Jefferies Securities Inc. and another Jefferies entity (and distributed by Jefferies Securities Inc.).",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "dd06c3ad18e9421f",
      "text": "Where Jefferies Securities Inc. distributes research reports produced by Jefferies LLC, Jefferies International Limited, Jefferies (Japan) Limited, Tokyo Branch or Jefferies India Private Limited, you are advised that each of Jefferies LLC, Jefferies International Limited, Jefferies (Japan) Limited, Tokyo Branch and Jefferies India Private Limited operates as a dealer in your jurisdiction under an exemption from the dealer registration requirements contained in National Instrument 31- 103 Registration Requirements, Exemptions and Ongoing Registrant Obligations and, as such, each of Jefferies LLC, Jefferies International Limited, Jefferies (Japan) Limited, Tokyo Branch and Jefferies India Private Limited is not required to be and is not a registered dealer or adviser in your jurisdiction. You are advised that where Jefferies LLC or Jefferies International Limited prepared this research report, it was not prepared in accordance with Canadian disclosure requirements relating to research reports in Canada.",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "f8009335fee537f5",
      "text": "United Kingdom: Jefferies International Limited, which is authorized and regulated by the Financial Conduct Authority, registered in England and Wales No. 1978621; registered office: 100 Bishopsgate, London EC2N 4JL; telephone +44 (0)20 7029 8000; facsimile +44 (0)20 7029 8010.",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "73b5a4502a91d08f",
      "text": "Japan: Jefferies (Japan) Limited, Tokyo Branch, which is a securities company registered by the Financial Services Agency of Japan and is a member of the Japan Securities Dealers Association; located at Tokyo Midtown Hibiya 30F Hibiya Mitsui Tower, 1- 1- 2 Yurakucho, Chiyoda- ku, Tokyo 100- 0006; telephone +813 5251 6100; facsimile +813 5251 6101.",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "fba2a5091eb59566",
      "text": "Australia: Jefferies (Australia) Pty Limited (ACN 623 059 898), which holds an Australian financial services license (AFSL 504712) and is located at Level 20, 60 Martin Place, Sydney NSW 2000; telephone +61 2 9364 2800.",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "bd864df17184d049",
      "text": "Dubai: Jefferies International Limited, Dubai branch, which is licensed by the Dubai Financial Services Authority (DFSA Reference Number F007325); registered office Unit L31- 06, L31- 07, Level 31, ICD Brookfield Pace, DIFC, PO Box 121208, Dubai, UAE.",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "73000ef3f35aee83",
      "text": "This report was prepared by personnel who are associated with Jefferies (Jefferies Securities Inc., Jefferies International Limited, Jefferies GmbH, Jefferies Hong Kong Limited, Jefferies Singapore Limited, Jefferies (Japan) Limited, Tokyo Branch, Jefferies India Private Limited), and Jefferies (Australia) Pty Ltd; or by personnel who are associated with both Jefferies LLC and Jefferies Research Services LLC (\"JRS\"). Jefferies LLC is a US registered broker- dealer and is affiliated with JRS, which is a US registered investment adviser. JRS does not create tailored or personalized research and all research provided by JRS is impersonal. If you are paying separately for this research, it is being provided to you by JRS. Otherwise, it is being provided by Jefferies LLC. Jefferies LLC, JRS, and their affiliates are collectively referred to below as \"Jefferies\". Jefferies may seek to do business with companies covered in this research report. As a result, investors should be aware that Jefferies may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only one of many factors in making their investment decisions. Specific conflict of interest and other disclosures that are required by FINRA, the Canadian Investment Regulatory Organization and other rules are set forth in this disclosure section.",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "cb83099ffc39ac42",
      "text": "If you are receiving this report from a non- US Jefferies entity, please note the following: Unless prohibited by the provisions of Regulation S of the U.S. Securities Act of 1933, as amended, this material is distributed in the United States by Jefferies LLC, which accepts responsibility for its contents in accordance with the provisions of Rule 15a- 6 under the US Securities Exchange Act of 1934, as amended. Transactions by or on behalf of any US person may only be effected through Jefferies LLC. In the United Kingdom and European Economic Area this report is issued and/or approved for distribution by Jefferies International Limited (\"JIL\") and/or Jefferies GmbH and is intended for use only by persons who have, or have been assessed as having, suitable professional experience and expertise, or by persons to whom it can be otherwise lawfully distributed. Jefferies LLC, JIL, Jefferies GmbH and their affiliates, may make a market or provide liquidity in the financial instruments referred to in this report; and where they do make a market, such activity is disclosed specifically in this report under \"company specific disclosures\".",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "e304feca6cb712f3",
      "text": "For Canadian investors, this material is intended for use only by professional or institutional investors. None of the investments or investment services mentioned or described herein is available to other persons or to anyone in Canada who is not a permitted client as defined by National Instrument 31- 103 Registration Requirements, Exemptions and Ongoing Registrant Obligations, as applicable. This research report is a general discussion of the merits and risks of a security or securities only, and is not in any way meant to be tailored to the needs and circumstances of any recipient. The information contained herein is not, and under no circumstances is to be construed as, an offer to sell securities described herein, or solicitation of an offer to buy securities described herein, in Canada or any province or territory thereof. Any offer or sale of the securities described herein in Canada will be made only under an exemption from the requirements to file a prospectus with the relevant Canadian securities regulators, if applicable, and only by a dealer properly registered under applicable securities laws or, alternatively, pursuant to an exemption from the dealer registration requirement in the relevant province or territory of Canada in which such offer or sale is made. The information contained herein is under no circumstances to be construed as investment advice in any province or territory of Canada and is not tailored to the needs of the recipient. To the extent that the information contained herein references securities of an issuer incorporated, formed or created under the laws of Canada or a province or territory of Canada, any trades in such securities must be conducted through a dealer registered in Canada. No securities commission or similar regulatory authority in Canada has reviewed or in any way passed judgment upon this research report, the information contained herein or the merits of the securities described herein, and any representation to the contrary is an offence.",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "10b9466bf31d6ea1",
      "text": "By providing this report, neither JRS nor any other Jefferies entity accepts any authority, discretion, or control over the management of the recipient's assets. Any action taken by the recipient of this report, based on the information in the report, is at the recipient's sole judgment and risk. The recipient must perform his or her own independent review of any prospective investment. If the recipient uses the services of Jefferies LLC (or other affiliated broker-dealers), in connection with a purchase or sale of a security that is a subject of these materials, such broker- dealer may act as principal for its own accounts or as agent for another person. Only JRS is registered with the SEC as an investment adviser, and therefore neither Jefferies LLC nor any other Jefferies affiliate has any fiduciary duty in connection with distribution of these reports.",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "c8111fa65666580c",
      "text": "The price and value of the investments referred to herein and the income from them may fluctuate. Past performance is not a guide to future performance, future returns are not guaranteed, and a loss of original capital may occur. Fluctuations in exchange rates could have adverse effects on the value or price of, or income derived from, certain investments.",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "2b75a3bffeabda58",
      "text": "This report may contain forward looking statements that may be affected by inaccurate assumptions or by known or unknown risks, uncertainties, and other important factors. As a result, the actual results, events, performance or achievements of the financial product may be materially different from those expressed or implied in such statements.",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "a48e354d2157be33",
      "text": "This report has been prepared independently of any issuer of securities mentioned herein and not as agent of any issuer of securities. No Equity Research personnel have authority whatsoever to make any representations or warranty on behalf of the issuer(s). Any comments or statements made herein are those of the Jefferies entity producing this report and may differ from the views of other Jefferies entities.",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "634745bf8cd47f86",
      "text": "This report may contain information obtained from third parties, including ratings from credit ratings agencies such as Standard & Poor's, and information derived from third-party or proprietary generative artificial intelligence (Gen AI) models. Jefferies does not guarantee the accuracy, completeness, timeliness or availability of this information, and is not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, or for the results obtained from the use of such content. Neither Jefferies nor any third-party content providers, including providers of Gen AI models, give any express or implied warranties, including, but not limited to, any warranties of merchantability or fitness for a particular purpose or use. Neither Jefferies nor any third-party content provider shall be liable for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including lost income or profits and opportunity costs) in connection with any use of their content, including ratings. Credit ratings are statements of opinions and are not statements of fact or recommendations to purchase, hold or sell securities. They do not address the suitability of securities or the suitability of securities for investment purposes, and should not be relied on as investment advice. Reproduction and distribution of third party content in any form is prohibited except with the prior written permission of the related third party.",
      "page": 9,
      "section": null
    },
    {
      "passage_id": "6c8e039d3b4de4a7",
      "text": "Jefferies research reports are disseminated and available electronically, and, in some cases, also in printed form. Electronic research is simultaneously made available to all clients. This report or any portion hereof may not be copied, reprinted, sold, or redistributed or disclosed by the recipient or any third party, by content scraping or extraction, automated processing, or any other form or means, without the prior written consent of Jefferies. Any unauthorized use is prohibited. Neither Jefferies nor any of its respective directors, officers or employees, is responsible for guaranteeing the financial success of any investment, or accepts any liability whatsoever for any direct, indirect or consequential damages or losses arising from any use of this report or its contents. Nothing herein shall be construed to waive any liability Jefferies has under applicable U.S. federal or state securities laws.",
      "page": 9,
      "section": null
    },
    {
      "passage_id": "886f59f95f175d04",
      "text": "For Important Disclosure information relating to JRS, please see https://adviserinfo.sec.gov/IAPD/Content/Common/crd_iapd_Brochure.aspx? BRCHR_VRSN_ID=483878 and https://adviserinfo.sec.gov/Firm/292142 or visit our website at https://javatar.bluematrix.com/sellside/Disclosures.action, or www.jefferies.com, or call 1.888.JEFFERIES.",
      "page": 9,
      "section": null
    }
  ],
  "entities": [
    {
      "entity_id": "8b1bfd70145c01f0",
      "name": "Avg USD",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "a1b44e4ffdeec408",
      "name": "Baptist Health",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "091ea27f0512d847",
      "name": "Base Case",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "7860a2554c61a53f",
      "name": "Canadian Investment",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "ccac99c92af4d9cc",
      "name": "Catalysts\n\nFocal",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "6e4788dbad025b7b",
      "name": "Company Description",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "ba87032713b76abb",
      "name": "Company Targets",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "8bb7d9a681cb9e40",
      "name": "Company Valuation",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "d89e36b8c93e016d",
      "name": "Core Biz",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "4b9be408e155a05b",
      "name": "Coverage Suspended",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "e9cd18ef1469e32c",
      "name": "DFSA Reference",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "6ba4b0a762d135f4",
      "name": "Dealers Association",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "44d7abf456cffe47",
      "name": "Devices\n\nEDAP",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "ef7939250a8b4d95",
      "name": "Differ\n\nWe",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "3a9f1e728b314846",
      "name": "Disclosures\n\nJefferies",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "98c5e1b74a254ba0",
      "name": "Downside Scenario",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "a87247c304f6889b",
      "name": "Dropped Coverage",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "8ed3fafbb18d7293",
      "name": "Dubai Financial",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "7b18535ae5e7f471",
      "name": "EDAP Income",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "ceb01188725a1a27",
      "name": "EDAP Revenue",
      "type": "company",
      "aliases": []
    }
  ],
  "data": {
    "figures": [
      {
        "type": "other",
        "title": null,
        "page": 1,
        "axes": null,
        "series": [],
        "figure_id": "07d3a88774de1c35",
        "provenance": {
          "page": 1
        }
      },
      {
        "type": "line",
        "title": null,
        "page": 2,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "2024",
              "2025",
              "+12 mo."
            ]
          },
          "y": {
            "unit": null,
            "range": {
              "min": 1,
              "max": 9
            }
          }
        },
        "series": [
          {
            "name": "Historical Data",
            "unit": null,
            "values": [
              {
                "x": "2024-01",
                "y": 6.5
              },
              {
                "x": "2024-02",
                "y": 7.0
              },
              {
                "x": "2024-03",
                "y": 6.5
              },
              {
                "x": "2024-04",
                "y": 7.0
              },
              {
                "x": "2024-05",
                "y": 4.5
              },
              {
                "x": "2024-06",
                "y": 5.5
              },
              {
                "x": "2024-07",
                "y": 5.0
              },
              {
                "x": "2024-08",
                "y": 6.0
              },
              {
                "x": "2024-09",
                "y": 7.0
              },
              {
                "x": "2024-10",
                "y": 8.0
              },
              {
                "x": "2024-11",
                "y": 7.0
              },
              {
                "x": "2024-12",
                "y": 6.0
              },
              {
                "x": "2025-01",
                "y": 5.0
              },
              {
                "x": "2025-02",
                "y": 4.0
              },
              {
                "x": "2025-03",
                "y": 3.5
              },
              {
                "x": "2025-04",
                "y": 3.0
              },
              {
                "x": "2025-05",
                "y": 2.5
              },
              {
                "x": "2025-06",
                "y": 2.0
              },
              {
                "x": "2025-07",
                "y": 1.5
              },
              {
                "x": "2025-08",
                "y": 2.0
              },
              {
                "x": "2025-09",
                "y": 1.5
              },
              {
                "x": "2025-10",
                "y": 1.4
              }
            ]
          },
          {
            "name": "Forecast - Upper Bound",
            "unit": null,
            "values": [
              {
                "x": "2025-10",
                "y": 1.4
              },
              {
                "x": "+12 mo.",
                "y": 2.5
              }
            ]
          },
          {
            "name": "Forecast - Mid Point",
            "unit": null,
            "values": [
              {
                "x": "2025-10",
                "y": 1.4
              },
              {
                "x": "+12 mo.",
                "y": 1.8
              }
            ]
          },
          {
            "name": "Forecast - Lower Bound",
            "unit": null,
            "values": [
              {
                "x": "2025-10",
                "y": 1.4
              },
              {
                "x": "+12 mo.",
                "y": 1.5
              }
            ]
          }
        ],
        "figure_id": "2a8aedefba784714",
        "provenance": {
          "page": 2
        }
      },
      {
        "type": "other",
        "title": "Jefferie",
        "page": 3,
        "axes": {},
        "series": [],
        "figure_id": "fab2d146203b3e64",
        "provenance": {
          "page": 3
        }
      },
      {
        "type": "other",
        "title": null,
        "page": 3,
        "axes": null,
        "series": [],
        "figure_id": "87b9899b7e4d76c3",
        "provenance": {
          "page": 3
        }
      },
      {
        "type": "bar",
        "title": "2023年中国新能源汽车销量预测",
        "page": 3,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "1月",
              "2月",
              "3月",
              "4月",
              "5月",
              "6月",
              "7月",
              "8月",
              "9月",
              "10月",
              "11月",
              "12月"
            ]
          },
          "y": {
            "unit": "万辆",
            "range": {
              "min": 0,
              "max": 100
            }
          }
        },
        "series": [
          {
            "name": "销量",
            "unit": "万辆",
            "values": [
              38.9,
              43.9,
              65.3,
              63.6,
              71.7,
              80.6,
              78,
              84.5,
              90.4,
              95.6,
              98.7,
              99.5
            ]
          }
        ],
        "figure_id": "8de788bb1ad416e7",
        "provenance": {
          "page": 3
        }
      },
      {
        "type": "line",
        "title": "Rating and Price Target History for: EDAP TMS (EDAP) as of 08-27-2025",
        "page": 6,
        "axes": {
          "x": {
            "type": "category",
            "labels": [
              "Oct 22",
              "Jan 23",
              "Apr 23",
              "Jul 23",
              "Oct 23",
              "Jan 24",
              "Apr 24",
              "Jul 24",
              "Oct 24",
              "Jan 25",
              "Apr 25",
              "Jul 25"
            ]
          },
          "y": {
            "unit": "USD",
            "range": {
              "min": 0,
              "max": 14
            }
          }
        },
        "series": [
          {
            "name": "Price",
            "unit": "USD",
            "values": [
              {
                "date": "11/01/2022",
                "price_target": 11.0,
                "action": "BUY"
              },
              {
                "date": "11/02/2022",
                "price_target": 13.0,
                "action": "BUY"
              },
              {
                "date": "11/17/2022",
                "price_target": 14.0,
                "action": "BUY"
              },
              {
                "date": "11/09/2023",
                "price_target": 12.0,
                "action": "BUY"
              },
              {
                "date": "08/28/2024",
                "price_target": 10.0,
                "action": "BUY"
              },
              {
                "date": "11/07/2024",
                "price_target": 8.0,
                "action": "BUY"
              },
              {
                "date": "04/03/2025",
                "price_target": 2.0,
                "action": "HOLD"
              },
              {
                "date": "05/15/2025",
                "price_target": 1.75,
                "action": "HOLD"
              }
            ]
          }
        ],
        "figure_id": "19e2dba867105ac0",
        "provenance": {
          "page": 6
        }
      }
    ],
    "tables": [],
    "numerical_data": [
      {
        "num_id": "709987a232cbfcfd",
        "value": 0.05,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "lies & Devices EDAP TMS ![Figure 0-0](images/0_0.jpg) 2Q Sales Beat; (+)12 F installs; HIFU Vols +5%;Raised HIFU Guide; &#36;100 PT 2Q sales increased 9% and beat cons driven by a healthy 12 Focal On",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "20f2cc1bac47ed47",
        "value": 0.09,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "2Q Sales Beat; (+)12 F installs; HIFU Vols +5%;Raised HIFU Guide; &#36;100 PT 2Q sales increased 9% and beat cons driven by a healthy 12 Focal One placements (&lt;cons). US HIFU procedure growth of ~",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "e87ff176cdc4041d",
        "value": 0.05,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "and beat cons driven by a healthy 12 Focal One placements (&lt;cons). US HIFU procedure growth of ~5% remained subdued on payer pushback but EDAP noted some improvement here. No chg to capEx environme",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "52ed894906e87814",
        "value": -0.34,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "y LOI, which we think reduces equity raise risk. EDAP raised its FY25 HIFU sales growth guide to +26-34% on higher system sales. We raise estimates on the 2Q beat and raise PT to &#36;1.80. Reit. Hold",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "ed0a798a8ed16485",
        "value": -0.09,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "timates on the 2Q beat and raise PT to &#36;1.80. Reit. Hold. **2Q sales of ~&#36;18MM (EUR 16MM), -9% y/y, were above cons &#36;16MM. HIFU sales of EUR 8.5MM** grew 77% y/y on higher Focal One units ",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "cb4897169d692596",
        "value": 0.77,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "sales of ~&#36;18MM (EUR 16MM), -9% y/y, were above cons &#36;16MM. HIFU sales of EUR 8.5MM** grew 77% y/y on higher Focal One units sold y/y, +24% disposables growth, and HIFU procedure growth grew 5",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "bfee229039112b10",
        "value": 0.24,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "re above cons &#36;16MM. HIFU sales of EUR 8.5MM** grew 77% y/y on higher Focal One units sold y/y, +24% disposables growth, and HIFU procedure growth grew 5% (vs 4% prior qtr). Sales in non-core Lith",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "cda2393db13afaa4",
        "value": 0.05,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "77% y/y on higher Focal One units sold y/y, +24% disposables growth, and HIFU procedure growth grew 5% (vs 4% prior qtr). Sales in non-core Litho/Distribution of EUR 7.6MM declined 31% y/y, an expecte",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "10c8e9d3cd697dc3",
        "value": 0.04,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "on higher Focal One units sold y/y, +24% disposables growth, and HIFU procedure growth grew 5% (vs 4% prior qtr). Sales in non-core Litho/Distribution of EUR 7.6MM declined 31% y/y, an expected declin",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "cfaaec9afa1c6b73",
        "value": 0.31,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "cedure growth grew 5% (vs 4% prior qtr). Sales in non-core Litho/Distribution of EUR 7.6MM declined 31% y/y, an expected decline as EDAP strategically de-emphasizes the biz. Operating loss was EUR 5.8",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "14bdea06dd781642",
        "value": 0.15,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "tegically de-emphasizes the biz. Operating loss was EUR 5.8MM vs 6MM loss in 1Q25. **EDAP expects a 15% tariff impact on all goods transferred from France to the US. We estimate this could equate to &",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "41c2120b8fc0944e",
        "value": 0.77,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "rope markets and expects to commence a US BPH clin trial in early 2026. **HIFU sales of EUR 8.5MM, +77% y/y, incl 12 Focal One systems placed in 2Q, &gt; JeffE's 5 system forecast. 2Q placements incl ",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "e11bc3a6c284f9bc",
        "value": 0.05,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ng w/ mgmt noting several cases have been performed on the new system. **US HIFU procedure growth ~5% y/y, a slight acceleration vs +4% y/y in 1Q25 but down vs** **+33% y/y in 4Q24 w/ EDAP again calli",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "b9e30e97ad1d93ae",
        "value": 0.04,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ave been performed on the new system. **US HIFU procedure growth ~5% y/y, a slight acceleration vs +4% y/y in 1Q25 but down vs** **+33% y/y in 4Q24 w/ EDAP again calling out longer, more challenging p",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "9d2563a5f5293155",
        "value": 0.33,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "stem. **US HIFU procedure growth ~5% y/y, a slight acceleration vs +4% y/y in 1Q25 but down vs** **+33% y/y in 4Q24 w/ EDAP again calling out longer, more challenging payor reviews/approval** **proces",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "89bf384150023a29",
        "value": 0.24,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "works with market access partners to accelerate pre-authorizations. 2Q HIFU disposables sales grew 24% y/y. EDAP raised its FY guidance for HIFU sales growth to 26-34% vs 16-25% prior and reduced its ",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "aa10ff0c36186084",
        "value": -0.34,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ns. 2Q HIFU disposables sales grew 24% y/y. EDAP raised its FY guidance for HIFU sales growth to 26-34% vs 16-25% prior and reduced its guidance for the non-core ESWL and Distribution businesses now e",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "75b974d110f05180",
        "value": -0.25,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "U disposables sales grew 24% y/y. EDAP raised its FY guidance for HIFU sales growth to 26-34% vs 16-25% prior and reduced its guidance for the non-core ESWL and Distribution businesses now expecting a",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "aa8ad7ef55e31fd4",
        "value": -0.3,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ed its guidance for the non-core ESWL and Distribution businesses now expecting a FY25 decline of 25-30% vs 20-25% prior. **EDAP's higher HIFU growth outlook reflects stronger systems sales,higher ser",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "9ba500650c27affe",
        "value": -0.25,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "dance for the non-core ESWL and Distribution businesses now expecting a FY25 decline of 25-30% vs 20-25% prior. **EDAP's higher HIFU growth outlook reflects stronger systems sales,higher services revs",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "b3478ba176d34a8e",
        "value": 0.14,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>PRICE</td><td>&#36;1.58*</td></tr><tr><td>PRICE TARGET | % TO PT</td><td>&#36;1.80 (&#36;1.75) | +14%</td></tr><tr><td>52W HIGH-LOW</td><td>&#36;3.77 - &#36;1.21</td></tr><tr><td>FLOAT (%) | ADV MM",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "410b3d6dec69679b",
        "value": 0.0,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "tr><td>52W HIGH-LOW</td><td>&#36;3.77 - &#36;1.21</td></tr><tr><td>FLOAT (%) | ADV MM (USD)</td><td>0.0% | 0.12</td></tr><tr><td>MARKET CAP</td><td>&#36;59.1M</td></tr><tr><td>TICKER</td><td>EDAP</td>",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "809481df690230af",
        "value": 0.09,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "F vs CONS</td></tr><tr><td>2025</td><td>2026</td><td>2025</td><td>2026</td></tr><tr><td>REV</td><td>+9%</td><td>+2%</td><td>-7%</td><td>-18%</td></tr><tr><td>EPS</td><td>+7%</td><td>+10%</td><td>-36%<",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "85dd7656c5ef8e88",
        "value": 0.02,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d></tr><tr><td>2025</td><td>2026</td><td>2025</td><td>2026</td></tr><tr><td>REV</td><td>+9%</td><td>+2%</td><td>-7%</td><td>-18%</td></tr><tr><td>EPS</td><td>+7%</td><td>+10%</td><td>-36%</td><td>-77%",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "3f6243fa2930c2fb",
        "value": -0.07,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>2025</td><td>2026</td><td>2025</td><td>2026</td></tr><tr><td>REV</td><td>+9%</td><td>+2%</td><td>-7%</td><td>-18%</td></tr><tr><td>EPS</td><td>+7%</td><td>+10%</td><td>-36%</td><td>-77%</td></tr></",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "eea50419e226723f",
        "value": -0.18,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>2026</td><td>2025</td><td>2026</td></tr><tr><td>REV</td><td>+9%</td><td>+2%</td><td>-7%</td><td>-18%</td></tr><tr><td>EPS</td><td>+7%</td><td>+10%</td><td>-36%</td><td>-77%</td></tr></table> <tabl",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "54b5f01ed206f8ad",
        "value": 0.07,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td></tr><tr><td>REV</td><td>+9%</td><td>+2%</td><td>-7%</td><td>-18%</td></tr><tr><td>EPS</td><td>+7%</td><td>+10%</td><td>-36%</td><td>-77%</td></tr></table> <table><tr><td>EPS</td><td>(0.20)</td><",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "25eb22b38c8fa116",
        "value": 0.1,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "r><td>REV</td><td>+9%</td><td>+2%</td><td>-7%</td><td>-18%</td></tr><tr><td>EPS</td><td>+7%</td><td>+10%</td><td>-36%</td><td>-77%</td></tr></table> <table><tr><td>EPS</td><td>(0.20)</td><td>(+0.17)</",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "b8d3fc0032d27477",
        "value": -0.36,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>+9%</td><td>+2%</td><td>-7%</td><td>-18%</td></tr><tr><td>EPS</td><td>+7%</td><td>+10%</td><td>-36%</td><td>-77%</td></tr></table> <table><tr><td>EPS</td><td>(0.20)</td><td>(+0.17)</td><td>(+0.23",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "aa65c4836b0ad256",
        "value": -0.77,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>+2%</td><td>-7%</td><td>-18%</td></tr><tr><td>EPS</td><td>+7%</td><td>+10%</td><td>-36%</td><td>-77%</td></tr></table> <table><tr><td>EPS</td><td>(0.20)</td><td>(+0.17)</td><td>(+0.23)</td><td>(+0",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "04802eda77923076",
        "value": 0.04,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "based on \\~0.5 - 1x EV/ sales on 2026E sales of\\) \\ \\(60MM\\) We forecast a 3- year sales CAGR of - 4%, which includes HIFU prostate procedure volume growth in the US. Our PT assumes the multiple holds",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "f4ae327300064cec",
        "value": 0.07,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "(EV/sales multiple on our 2026 sales estimate of\\) \\ \\(54MM\\) We forecast a 3 year sales CAGR of - 7%, which includes a modest pace of HIFU prostate procedure adoption and a slowdown in US system plac",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "5a7d64eda16974e9",
        "value": -0.34,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "mages/2_0.jpg) ![Figure 2-1](images/2_1.jpg) **FY25 Guidance: Raised HIFU Sales Growth Guidance 26-34% on Stronger System Placements; Non-**Core Biz to Decline 25-30% ![Figure 2-2](images/2_2.jpg) EDA",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "4b1d3ba25d217170",
        "value": -0.3,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "Raised HIFU Sales Growth Guidance 26-34% on Stronger System Placements; Non-**Core Biz to Decline 25-30% ![Figure 2-2](images/2_2.jpg) EDAP raised its FY25 guidance for HIFU growth to 26-34% vs 16-25%",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "0bd44341caf282fe",
        "value": -0.34,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "o Decline 25-30% ![Figure 2-2](images/2_2.jpg) EDAP raised its FY25 guidance for HIFU growth to 26-34% vs 16-25% prior and reduced its guidance for the non-core ESWL and Distribution businesses now ex",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "2559e82ffcd9ffa4",
        "value": -0.25,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "25-30% ![Figure 2-2](images/2_2.jpg) EDAP raised its FY25 guidance for HIFU growth to 26-34% vs 16-25% prior and reduced its guidance for the non-core ESWL and Distribution businesses now expecting a ",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "f344295d70d5b76b",
        "value": -0.3,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ed its guidance for the non-core ESWL and Distribution businesses now expecting a FY25 decline of 25-30%vs 20-25% prior. **EDAP's higher HIFU growth outlook reflects stronger systems sales, higher ser",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "0550f0ce4c25d59d",
        "value": -0.25,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "idance for the non-core ESWL and Distribution businesses now expecting a FY25 decline of 25-30%vs 20-25% prior. **EDAP's higher HIFU growth outlook reflects stronger systems sales, higher services** *",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "4663c3a1a4323dc6",
        "value": -0.08,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td> &#36;66</td><td>&#36;68</td><td>&#36;70</td><td></td></tr><tr><td>% Reported growth</td><td>-8%</td><td>-4%</td><td>-1%</td><td>-8%</td><td>-4%</td><td>-1%</td><td>-5%</td><td>-2%</td><td>2%</",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "ad2c230f618b6642",
        "value": -0.04,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ";66</td><td>&#36;68</td><td>&#36;70</td><td></td></tr><tr><td>% Reported growth</td><td>-8%</td><td>-4%</td><td>-1%</td><td>-8%</td><td>-4%</td><td>-1%</td><td>-5%</td><td>-2%</td><td>2%</td><td></td>",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "a099abf25e5a52ba",
        "value": -0.01,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "&#36;68</td><td>&#36;70</td><td></td></tr><tr><td>% Reported growth</td><td>-8%</td><td>-4%</td><td>-1%</td><td>-8%</td><td>-4%</td><td>-1%</td><td>-5%</td><td>-2%</td><td>2%</td><td></td></tr><tr><td",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "6cbd05699e12b52b",
        "value": -0.08,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>&#36;70</td><td></td></tr><tr><td>% Reported growth</td><td>-8%</td><td>-4%</td><td>-1%</td><td>-8%</td><td>-4%</td><td>-1%</td><td>-5%</td><td>-2%</td><td>2%</td><td></td></tr><tr><td>Avg USD/EUR",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "28d55f023ff46885",
        "value": -0.04,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td></td></tr><tr><td>% Reported growth</td><td>-8%</td><td>-4%</td><td>-1%</td><td>-8%</td><td>-4%</td><td>-1%</td><td>-5%</td><td>-2%</td><td>2%</td><td></td></tr><tr><td>Avg USD/EUR FX Rate</td",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "0c8298339f3836e9",
        "value": -0.01,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "></tr><tr><td>% Reported growth</td><td>-8%</td><td>-4%</td><td>-1%</td><td>-8%</td><td>-4%</td><td>-1%</td><td>-5%</td><td>-2%</td><td>2%</td><td></td></tr><tr><td>Avg USD/EUR FX Rate</td><td>1.10</t",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "d468f9af2f857189",
        "value": -0.05,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>% Reported growth</td><td>-8%</td><td>-4%</td><td>-1%</td><td>-8%</td><td>-4%</td><td>-1%</td><td>-5%</td><td>-2%</td><td>2%</td><td></td></tr><tr><td>Avg USD/EUR FX Rate</td><td>1.10</td><td>1.10</",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "f4eee186e42f2bec",
        "value": -0.02,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "growth</td><td>-8%</td><td>-4%</td><td>-1%</td><td>-8%</td><td>-4%</td><td>-1%</td><td>-5%</td><td>-2%</td><td>2%</td><td></td></tr><tr><td>Avg USD/EUR FX Rate</td><td>1.10</td><td>1.10</td><td>1.10</",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "0d88033b383a4c1f",
        "value": 0.02,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>-8%</td><td>-4%</td><td>-1%</td><td>-8%</td><td>-4%</td><td>-1%</td><td>-5%</td><td>-2%</td><td>2%</td><td></td></tr><tr><td>Avg USD/EUR FX Rate</td><td>1.10</td><td>1.10</td><td>1.10</td><td>1.10",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "060d0399377ae3ec",
        "value": -0.1,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>&#36;58.2</td><td>&#36;60.2</td><td>&#36;62.2</td><td></td></tr><tr><td>% Reported growth</td><td>-10%</td><td>-7%</td><td>-3%</td><td>-10%</td><td>-7%</td><td>-3%</td><td>-9%</td><td>-6%</td><td>-3",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "3455727eeb80c5db",
        "value": -0.07,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>&#36;60.2</td><td>&#36;62.2</td><td></td></tr><tr><td>% Reported growth</td><td>-10%</td><td>-7%</td><td>-3%</td><td>-10%</td><td>-7%</td><td>-3%</td><td>-9%</td><td>-6%</td><td>-3%</td><td></t",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "84c18895c4bc3494",
        "value": -0.03,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "60.2</td><td>&#36;62.2</td><td></td></tr><tr><td>% Reported growth</td><td>-10%</td><td>-7%</td><td>-3%</td><td>-10%</td><td>-7%</td><td>-3%</td><td>-9%</td><td>-6%</td><td>-3%</td><td></td></tr><tr><",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "c22bbce82a6be07d",
        "value": -0.1,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">&#36;62.2</td><td></td></tr><tr><td>% Reported growth</td><td>-10%</td><td>-7%</td><td>-3%</td><td>-10%</td><td>-7%</td><td>-3%</td><td>-9%</td><td>-6%</td><td>-3%</td><td></td></tr><tr><td>HIFU sale",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "2fe2e219b6a3ccf3",
        "value": -0.07,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td></td></tr><tr><td>% Reported growth</td><td>-10%</td><td>-7%</td><td>-3%</td><td>-10%</td><td>-7%</td><td>-3%</td><td>-9%</td><td>-6%</td><td>-3%</td><td></td></tr><tr><td>HIFU sales (EUR)</td><",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "796bafcc9590126c",
        "value": -0.03,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/tr><tr><td>% Reported growth</td><td>-10%</td><td>-7%</td><td>-3%</td><td>-10%</td><td>-7%</td><td>-3%</td><td>-9%</td><td>-6%</td><td>-3%</td><td></td></tr><tr><td>HIFU sales (EUR)</td><td>&#36;27.7",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "233420f170f5ccad",
        "value": -0.09,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "% Reported growth</td><td>-10%</td><td>-7%</td><td>-3%</td><td>-10%</td><td>-7%</td><td>-3%</td><td>-9%</td><td>-6%</td><td>-3%</td><td></td></tr><tr><td>HIFU sales (EUR)</td><td>&#36;27.7</td><td>&#3",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "67fd856618a16386",
        "value": -0.06,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "rowth</td><td>-10%</td><td>-7%</td><td>-3%</td><td>-10%</td><td>-7%</td><td>-3%</td><td>-9%</td><td>-6%</td><td>-3%</td><td></td></tr><tr><td>HIFU sales (EUR)</td><td>&#36;27.7</td><td>&#36;28.7</td><",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "ae58eb036ad743a2",
        "value": -0.03,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>-10%</td><td>-7%</td><td>-3%</td><td>-10%</td><td>-7%</td><td>-3%</td><td>-9%</td><td>-6%</td><td>-3%</td><td></td></tr><tr><td>HIFU sales (EUR)</td><td>&#36;27.7</td><td>&#36;28.7</td><td>&#36;29.8",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "ec5e4d9106e6eca1",
        "value": 0.16,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ".8</td><td>&#30.0</td><td>&#31.0</td><td>&#31.9</td><td></td></tr><tr><td>% Reported Growth</td><td>16%</td><td>21%</td><td>25%</td><td>16%</td><td>21%</td><td>25%</td><td>26%</td><td>30%</td><td>34%<",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "f5478e732d7c8a70",
        "value": 0.21,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "#30.0</td><td>&#31.0</td><td>&#31.9</td><td></td></tr><tr><td>% Reported Growth</td><td>16%</td><td>21%</td><td>25%</td><td>16%</td><td>21%</td><td>25%</td><td>26%</td><td>30%</td><td>34%</td><td>26-3",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "8540c2625089a9e4",
        "value": 0.25,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>&#31.0</td><td>&#31.9</td><td></td></tr><tr><td>% Reported Growth</td><td>16%</td><td>21%</td><td>25%</td><td>16%</td><td>21%</td><td>25%</td><td>26%</td><td>30%</td><td>34%</td><td>26-34% y/y sales",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "755124cb3599dbb0",
        "value": 0.16,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>&#31.9</td><td></td></tr><tr><td>% Reported Growth</td><td>16%</td><td>21%</td><td>25%</td><td>16%</td><td>21%</td><td>25%</td><td>26%</td><td>30%</td><td>34%</td><td>26-34% y/y sales growth</td>",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "0902d8a15abb8d4f",
        "value": 0.21,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td></td></tr><tr><td>% Reported Growth</td><td>16%</td><td>21%</td><td>25%</td><td>16%</td><td>21%</td><td>25%</td><td>26%</td><td>30%</td><td>34%</td><td>26-34% y/y sales growth</td></tr><tr><td",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "7c0ec1ec1ad10b9c",
        "value": 0.25,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "></tr><tr><td>% Reported Growth</td><td>16%</td><td>21%</td><td>25%</td><td>16%</td><td>21%</td><td>25%</td><td>26%</td><td>30%</td><td>34%</td><td>26-34% y/y sales growth</td></tr><tr><td>ESWL (Litho",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "ae710f2795e66caa",
        "value": 0.26,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>% Reported Growth</td><td>16%</td><td>21%</td><td>25%</td><td>16%</td><td>21%</td><td>25%</td><td>26%</td><td>30%</td><td>34%</td><td>26-34% y/y sales growth</td></tr><tr><td>ESWL (Lithotripsy) Sale",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "ef4f0c25afcb1a3e",
        "value": 0.3,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "Growth</td><td>16%</td><td>21%</td><td>25%</td><td>16%</td><td>21%</td><td>25%</td><td>26%</td><td>30%</td><td>34%</td><td>26-34% y/y sales growth</td></tr><tr><td>ESWL (Lithotripsy) Sales (EUR)</td><",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "1dc03d3614075c9e",
        "value": 0.34,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>16%</td><td>21%</td><td>25%</td><td>16%</td><td>21%</td><td>25%</td><td>26%</td><td>30%</td><td>34%</td><td>26-34% y/y sales growth</td></tr><tr><td>ESWL (Lithotripsy) Sales (EUR)</td><td>&#36;6.7",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "fcc918e14554b5f4",
        "value": -0.34,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>21%</td><td>25%</td><td>16%</td><td>21%</td><td>25%</td><td>26%</td><td>30%</td><td>34%</td><td>26-34% y/y sales growth</td></tr><tr><td>ESWL (Lithotripsy) Sales (EUR)</td><td>&#36;6.7</td><td>&#36;",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "63c9839209f8b7c7",
        "value": -0.25,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>&#36;6.3</td><td>&#36;6.5</td><td>&#36;6.7</td><td></td></tr><tr><td>% Reported Growth</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-30%</td><td>-28%</td>",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "82021bfbcb6e6002",
        "value": -0.23,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>&#36;6.5</td><td>&#36;6.7</td><td></td></tr><tr><td>% Reported Growth</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-30%</td><td>-28%</td><td>-25%</td>",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "2052493b884dbb13",
        "value": -0.2,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ";6.5</td><td>&#36;6.7</td><td></td></tr><tr><td>% Reported Growth</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-30%</td><td>-28%</td><td>-25%</td><td>25-30% y/",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "5a567e6339149311",
        "value": -0.25,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "&#36;6.7</td><td></td></tr><tr><td>% Reported Growth</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-30%</td><td>-28%</td><td>-25%</td><td>25-30% y/y sales decli",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "c3609ec5fa6697e1",
        "value": -0.23,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td></td></tr><tr><td>% Reported Growth</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-30%</td><td>-28%</td><td>-25%</td><td>25-30% y/y sales decline</td></tr><",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "573063de6a1a8fb8",
        "value": -0.2,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><tr><td>% Reported Growth</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-30%</td><td>-28%</td><td>-25%</td><td>25-30% y/y sales decline</td></tr><tr><td>Distri",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "24da66fd2049fe6a",
        "value": -0.3,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ported Growth</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-30%</td><td>-28%</td><td>-25%</td><td>25-30% y/y sales decline</td></tr><tr><td>Distribution sales ",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "024e31fe61a9cf5b",
        "value": -0.28,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-30%</td><td>-28%</td><td>-25%</td><td>25-30% y/y sales decline</td></tr><tr><td>Distribution sales (EUR)</td><td",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "a70db93cf79b4d54",
        "value": -0.25,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>-23%</td><td>-20%</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-30%</td><td>-28%</td><td>-25%</td><td>25-30% y/y sales decline</td></tr><tr><td>Distribution sales (EUR)</td><td>&#36;23.5</t",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "668da9243883f734",
        "value": -0.3,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>-20%</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-30%</td><td>-28%</td><td>-25%</td><td>25-30% y/y sales decline</td></tr><tr><td>Distribution sales (EUR)</td><td>&#36;23.5</td><td>&#36;24.3",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "f745d41be8ca770a",
        "value": -0.25,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ".0</td><td>&#32.9</td><td>&#32.7</td><td>&#35.5</td><td></td></tr><tr><td>% Reported Growth</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-30%</td><td>-28%</td>",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "ac892ca8f8e63741",
        "value": -0.23,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "32.9</td><td>&#32.7</td><td>&#35.5</td><td></td></tr><tr><td>% Reported Growth</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-30%</td><td>-28%</td><td>-25%</td>",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "1b2266215b56d53c",
        "value": -0.2,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "&#32.7</td><td>&#35.5</td><td></td></tr><tr><td>% Reported Growth</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-30%</td><td>-28%</td><td>-25%</td><td>25-30% y/",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "d3a3d08de1836275",
        "value": -0.25,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>&#35.5</td><td></td></tr><tr><td>% Reported Growth</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-30%</td><td>-28%</td><td>-25%</td><td>25-30% y/y sales decli",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "c3609ec5fa6697e1",
        "value": -0.23,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td></td></tr><tr><td>% Reported Growth</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-30%</td><td>-28%</td><td>-25%</td><td>25-30% y/y sales decline</td></tr><",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "573063de6a1a8fb8",
        "value": -0.2,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><tr><td>% Reported Growth</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-25%</td><td>-23%</td><td>-20%</td><td>-30%</td><td>-28%</td><td>-25%</td><td>25-30% y/y sales decline</td></tr></table> Sourc",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "fc0ed67468e7b2f7",
        "value": 0.11599999999999999,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>$14.9</td><td>$19.4</td><td>$67.0</td><td>$60.3</td><td>$62.5</td></tr><tr><td>% growth</td><td>11.6%</td><td>12.9%</td><td>5.5%</td><td>-11.4%</td><td>8.6%</td><td>3.1%</td><td>-9.6%</td><td>-2.9",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "cac82fe42e4db6f3",
        "value": 0.129,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>$19.4</td><td>$67.0</td><td>$60.3</td><td>$62.5</td></tr><tr><td>% growth</td><td>11.6%</td><td>12.9%</td><td>5.5%</td><td>-11.4%</td><td>8.6%</td><td>3.1%</td><td>-9.6%</td><td>-2.9%</td><td>-10.",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "183186fac9e27901",
        "value": 0.055,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>$67.0</td><td>$60.3</td><td>$62.5</td></tr><tr><td>% growth</td><td>11.6%</td><td>12.9%</td><td>5.5%</td><td>-11.4%</td><td>8.6%</td><td>3.1%</td><td>-9.6%</td><td>-2.9%</td><td>-10.0%</td><td>3.7",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "39db16d05be2b01c",
        "value": -0.114,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>$60.3</td><td>$62.5</td></tr><tr><td>% growth</td><td>11.6%</td><td>12.9%</td><td>5.5%</td><td>-11.4%</td><td>8.6%</td><td>3.1%</td><td>-9.6%</td><td>-2.9%</td><td>-10.0%</td><td>3.7%</td></tr><t",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "e049feb5f71a111c",
        "value": 0.086,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>$62.5</td></tr><tr><td>% growth</td><td>11.6%</td><td>12.9%</td><td>5.5%</td><td>-11.4%</td><td>8.6%</td><td>3.1%</td><td>-9.6%</td><td>-2.9%</td><td>-10.0%</td><td>3.7%</td></tr><tr><td>Cost of s",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "f2366be085174814",
        "value": 0.031,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "></tr><tr><td>% growth</td><td>11.6%</td><td>12.9%</td><td>5.5%</td><td>-11.4%</td><td>8.6%</td><td>3.1%</td><td>-9.6%</td><td>-2.9%</td><td>-10.0%</td><td>3.7%</td></tr><tr><td>Cost of sales</td><td>",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "3bb83f014982c6e2",
        "value": -0.096,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">% growth</td><td>11.6%</td><td>12.9%</td><td>5.5%</td><td>-11.4%</td><td>8.6%</td><td>3.1%</td><td>-9.6%</td><td>-2.9%</td><td>-10.0%</td><td>3.7%</td></tr><tr><td>Cost of sales</td><td>$32.5</td><td",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "39fa7faa1ec073af",
        "value": -0.028999999999999998,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>11.6%</td><td>12.9%</td><td>5.5%</td><td>-11.4%</td><td>8.6%</td><td>3.1%</td><td>-9.6%</td><td>-2.9%</td><td>-10.0%</td><td>3.7%</td></tr><tr><td>Cost of sales</td><td>$32.5</td><td>$39.0</td><td",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "1af39622936b0db2",
        "value": -0.1,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>12.9%</td><td>5.5%</td><td>-11.4%</td><td>8.6%</td><td>3.1%</td><td>-9.6%</td><td>-2.9%</td><td>-10.0%</td><td>3.7%</td></tr><tr><td>Cost of sales</td><td>$32.5</td><td>$39.0</td><td>$40.5</td><td",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "3e6f5177bf30c37a",
        "value": 0.037000000000000005,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>5.5%</td><td>-11.4%</td><td>8.6%</td><td>3.1%</td><td>-9.6%</td><td>-2.9%</td><td>-10.0%</td><td>3.7%</td></tr><tr><td>Cost of sales</td><td>$32.5</td><td>$39.0</td><td>$40.5</td><td>$8.3</td><td>$",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "0937ea1257c55226",
        "value": 0.439,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>$5.8</td><td>$8.0</td><td>$27.6</td><td>$25.9</td><td>$28.8</td></tr><tr><td>% of sales</td><td>43.9%</td><td>40.4%</td><td>41.4%</td><td>42.0%</td><td>42.5%</td><td>39.0%</td><td>41.0%</td><td>41",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "db5ca7a075970dc0",
        "value": 0.40399999999999997,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>$8.0</td><td>$27.6</td><td>$25.9</td><td>$28.8</td></tr><tr><td>% of sales</td><td>43.9%</td><td>40.4%</td><td>41.4%</td><td>42.0%</td><td>42.5%</td><td>39.0%</td><td>41.0%</td><td>41.2%</td><td>43",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "7f5b27073b0eaffc",
        "value": 0.414,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>$27.6</td><td>$25.9</td><td>$28.8</td></tr><tr><td>% of sales</td><td>43.9%</td><td>40.4%</td><td>41.4%</td><td>42.0%</td><td>42.5%</td><td>39.0%</td><td>41.0%</td><td>41.2%</td><td>43.0%</td><td>46",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "cd9abe33f573e4ee",
        "value": 0.42,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>$25.9</td><td>$28.8</td></tr><tr><td>% of sales</td><td>43.9%</td><td>40.4%</td><td>41.4%</td><td>42.0%</td><td>42.5%</td><td>39.0%</td><td>41.0%</td><td>41.2%</td><td>43.0%</td><td>46.0%</td></tr><",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "3d22bb6c8d6cdd90",
        "value": 0.425,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>$28.8</td></tr><tr><td>% of sales</td><td>43.9%</td><td>40.4%</td><td>41.4%</td><td>42.0%</td><td>42.5%</td><td>39.0%</td><td>41.0%</td><td>41.2%</td><td>43.0%</td><td>46.0%</td></tr><tr><td>SG&amp;",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "f87df547f9512ac3",
        "value": 0.39,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "tr><tr><td>% of sales</td><td>43.9%</td><td>40.4%</td><td>41.4%</td><td>42.0%</td><td>42.5%</td><td>39.0%</td><td>41.0%</td><td>41.2%</td><td>43.0%</td><td>46.0%</td></tr><tr><td>SG&amp;amp;A</td><td>",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "755ba37fa40fb31b",
        "value": 0.41,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "f sales</td><td>43.9%</td><td>40.4%</td><td>41.4%</td><td>42.0%</td><td>42.5%</td><td>39.0%</td><td>41.0%</td><td>41.2%</td><td>43.0%</td><td>46.0%</td></tr><tr><td>SG&amp;amp;A</td><td>$24.6</td><td>",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "3bdce9ba2f4ea1f8",
        "value": 0.41200000000000003,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>43.9%</td><td>40.4%</td><td>41.4%</td><td>42.0%</td><td>42.5%</td><td>39.0%</td><td>41.0%</td><td>41.2%</td><td>43.0%</td><td>46.0%</td></tr><tr><td>SG&amp;amp;A</td><td>$24.6</td><td>$40.3</td><td>",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "684aa7ab97e4b9ff",
        "value": 0.43,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>40.4%</td><td>41.4%</td><td>42.0%</td><td>42.5%</td><td>39.0%</td><td>41.0%</td><td>41.2%</td><td>43.0%</td><td>46.0%</td></tr><tr><td>SG&amp;amp;A</td><td>$24.6</td><td>$40.3</td><td>$42.4</td><td>",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "cf133a82296683ef",
        "value": 0.46,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>41.4%</td><td>42.0%</td><td>42.5%</td><td>39.0%</td><td>41.0%</td><td>41.2%</td><td>43.0%</td><td>46.0%</td></tr><tr><td>SG&amp;amp;A</td><td>$24.6</td><td>$40.3</td><td>$42.4</td><td>$9.7</td><td>$",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "702cf23a10c4e0d3",
        "value": 0.425,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>$12.6</td><td>$12.6</td><td>$46.9</td><td>$46.4</td><td>$47.2</td></tr><tr><td>% of sales</td><td>42.5%</td><td>61.6%</td><td>61.5%</td><td>68.1%</td><td>64.7%</td><td>85.0%</td><td>65.0%</td><td>70",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "1e6b2b620cfa6813",
        "value": 0.616,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>$12.6</td><td>$46.9</td><td>$46.4</td><td>$47.2</td></tr><tr><td>% of sales</td><td>42.5%</td><td>61.6%</td><td>61.5%</td><td>68.1%</td><td>64.7%</td><td>85.0%</td><td>65.0%</td><td>70.0%</td><td>77",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "0c2b07241d70dcb4",
        "value": 0.615,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>$46.9</td><td>$46.4</td><td>$47.2</td></tr><tr><td>% of sales</td><td>42.5%</td><td>61.6%</td><td>61.5%</td><td>68.1%</td><td>64.7%</td><td>85.0%</td><td>65.0%</td><td>70.0%</td><td>77.0%</td><td>75",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "0d702ff6b3d5421b",
        "value": 0.6809999999999999,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>$46.4</td><td>$47.2</td></tr><tr><td>% of sales</td><td>42.5%</td><td>61.6%</td><td>61.5%</td><td>68.1%</td><td>64.7%</td><td>85.0%</td><td>65.0%</td><td>70.0%</td><td>77.0%</td><td>75.5%</td></tr><",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "4db9fbb6440fd947",
        "value": 0.647,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>$47.2</td></tr><tr><td>% of sales</td><td>42.5%</td><td>61.6%</td><td>61.5%</td><td>68.1%</td><td>64.7%</td><td>85.0%</td><td>65.0%</td><td>70.0%</td><td>77.0%</td><td>75.5%</td></tr><tr><td>% growt",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "7ebd0588f422c017",
        "value": 0.85,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "tr><tr><td>% of sales</td><td>42.5%</td><td>61.6%</td><td>61.5%</td><td>68.1%</td><td>64.7%</td><td>85.0%</td><td>65.0%</td><td>70.0%</td><td>77.0%</td><td>75.5%</td></tr><tr><td>% growth</td><td>26%<",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "dba2f620e51686c5",
        "value": 0.65,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "f sales</td><td>42.5%</td><td>61.6%</td><td>61.5%</td><td>68.1%</td><td>64.7%</td><td>85.0%</td><td>65.0%</td><td>70.0%</td><td>77.0%</td><td>75.5%</td></tr><tr><td>% growth</td><td>26%</td><td>64%</t",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "43b956e081ebcdc7",
        "value": 0.7,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>42.5%</td><td>61.6%</td><td>61.5%</td><td>68.1%</td><td>64.7%</td><td>85.0%</td><td>65.0%</td><td>70.0%</td><td>77.0%</td><td>75.5%</td></tr><tr><td>% growth</td><td>26%</td><td>64%</td><td>5%</td><",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "23784b813bc9dcb4",
        "value": 0.77,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>61.6%</td><td>61.5%</td><td>68.1%</td><td>64.7%</td><td>85.0%</td><td>65.0%</td><td>70.0%</td><td>77.0%</td><td>75.5%</td></tr><tr><td>% growth</td><td>26%</td><td>64%</td><td>5%</td><td>-2%</td><td",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "d92d04bfa676887c",
        "value": 0.755,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>61.5%</td><td>68.1%</td><td>64.7%</td><td>85.0%</td><td>65.0%</td><td>70.0%</td><td>77.0%</td><td>75.5%</td></tr><tr><td>% growth</td><td>26%</td><td>64%</td><td>5%</td><td>-2%</td><td>11%</td><td>2",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "71be9e7d5ad22485",
        "value": 0.26,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>85.0%</td><td>65.0%</td><td>70.0%</td><td>77.0%</td><td>75.5%</td></tr><tr><td>% growth</td><td>26%</td><td>64%</td><td>5%</td><td>-2%</td><td>11%</td><td>24%</td><td>9%</td><td>11%</td><td>-1.1%<",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "3ac61fac4c2a2a28",
        "value": 0.64,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>65.0%</td><td>70.0%</td><td>77.0%</td><td>75.5%</td></tr><tr><td>% growth</td><td>26%</td><td>64%</td><td>5%</td><td>-2%</td><td>11%</td><td>24%</td><td>9%</td><td>11%</td><td>-1.1%</td><td>1.7%",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "98f45a2250ada38b",
        "value": 0.05,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td>70.0%</td><td>77.0%</td><td>75.5%</td></tr><tr><td>% growth</td><td>26%</td><td>64%</td><td>5%</td><td>-2%</td><td>11%</td><td>24%</td><td>9%</td><td>11%</td><td>-1.1%</td><td>1.7%</td></tr><t",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "fc85d596a065ed77",
        "value": -0.02,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "0%</td><td>77.0%</td><td>75.5%</td></tr><tr><td>% growth</td><td>26%</td><td>64%</td><td>5%</td><td>-2%</td><td>11%</td><td>24%</td><td>9%</td><td>11%</td><td>-1.1%</td><td>1.7%</td></tr><tr><td>R&amp",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "88dfc4aa95db4425",
        "value": 0.11,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "7.0%</td><td>75.5%</td></tr><tr><td>% growth</td><td>26%</td><td>64%</td><td>5%</td><td>-2%</td><td>11%</td><td>24%</td><td>9%</td><td>11%</td><td>-1.1%</td><td>1.7%</td></tr><tr><td>R&amp;amp;D</td><",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "ca87a8780f1b5c22",
        "value": 0.24,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">75.5%</td></tr><tr><td>% growth</td><td>26%</td><td>64%</td><td>5%</td><td>-2%</td><td>11%</td><td>24%</td><td>9%</td><td>11%</td><td>-1.1%</td><td>1.7%</td></tr><tr><td>R&amp;amp;D</td><td>$5.2</td>",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "1edb88e3a3d1cd4d",
        "value": 0.09,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/tr><tr><td>% growth</td><td>26%</td><td>64%</td><td>5%</td><td>-2%</td><td>11%</td><td>24%</td><td>9%</td><td>11%</td><td>-1.1%</td><td>1.7%</td></tr><tr><td>R&amp;amp;D</td><td>$5.2</td><td>$7.5</td",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "fe668eb09d0d3152",
        "value": 0.11,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">% growth</td><td>26%</td><td>64%</td><td>5%</td><td>-2%</td><td>11%</td><td>24%</td><td>9%</td><td>11%</td><td>-1.1%</td><td>1.7%</td></tr><tr><td>R&amp;amp;D</td><td>$5.2</td><td>$7.5</td><td>$8.3</",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "a202fbee9de350ea",
        "value": -0.011000000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>26%</td><td>64%</td><td>5%</td><td>-2%</td><td>11%</td><td>24%</td><td>9%</td><td>11%</td><td>-1.1%</td><td>1.7%</td></tr><tr><td>R&amp;amp;D</td><td>$5.2</td><td>$7.5</td><td>$8.3</td><td>$2.6<",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "999ea5fefd2c0f16",
        "value": 0.017,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>64%</td><td>5%</td><td>-2%</td><td>11%</td><td>24%</td><td>9%</td><td>11%</td><td>-1.1%</td><td>1.7%</td></tr><tr><td>R&amp;amp;D</td><td>$5.2</td><td>$7.5</td><td>$8.3</td><td>$2.6</td><td>$2.5</",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "a9d8af6be0cbbbcc",
        "value": 0.08900000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>$2.5</td><td>$2.7</td><td>$10.4</td><td>$9.3</td><td>$9.4</td></tr><tr><td>% of sales</td><td>8.9%</td><td>11.5%</td><td>12.1%</td><td>18.1%</td><td>13.8%</td><td>17.0%</td><td>14.0%</td><td>15.",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "6a69f4e6a3bb9281",
        "value": 0.115,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>$2.7</td><td>$10.4</td><td>$9.3</td><td>$9.4</td></tr><tr><td>% of sales</td><td>8.9%</td><td>11.5%</td><td>12.1%</td><td>18.1%</td><td>13.8%</td><td>17.0%</td><td>14.0%</td><td>15.5%</td><td>15",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "a60dff3f66ce29b8",
        "value": 0.121,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>$10.4</td><td>$9.3</td><td>$9.4</td></tr><tr><td>% of sales</td><td>8.9%</td><td>11.5%</td><td>12.1%</td><td>18.1%</td><td>13.8%</td><td>17.0%</td><td>14.0%</td><td>15.5%</td><td>15.5%</td><td>15",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "fea832c2de1d18dd",
        "value": 0.18100000000000002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>$9.3</td><td>$9.4</td></tr><tr><td>% of sales</td><td>8.9%</td><td>11.5%</td><td>12.1%</td><td>18.1%</td><td>13.8%</td><td>17.0%</td><td>14.0%</td><td>15.5%</td><td>15.5%</td><td>15.0%</td></tr><",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "0f4ff4f9dfe7682a",
        "value": 0.138,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>$9.4</td></tr><tr><td>% of sales</td><td>8.9%</td><td>11.5%</td><td>12.1%</td><td>18.1%</td><td>13.8%</td><td>17.0%</td><td>14.0%</td><td>15.5%</td><td>15.5%</td><td>15.0%</td></tr><tr><td>% growt",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "40fc93e28af631ad",
        "value": 0.17,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/tr><tr><td>% of sales</td><td>8.9%</td><td>11.5%</td><td>12.1%</td><td>18.1%</td><td>13.8%</td><td>17.0%</td><td>14.0%</td><td>15.5%</td><td>15.5%</td><td>15.0%</td></tr><tr><td>% growth</td><td>29%<",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "7e3b0e7da288b863",
        "value": 0.14,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "of sales</td><td>8.9%</td><td>11.5%</td><td>12.1%</td><td>18.1%</td><td>13.8%</td><td>17.0%</td><td>14.0%</td><td>15.5%</td><td>15.5%</td><td>15.0%</td></tr><tr><td>% growth</td><td>29%</td><td>46%</t",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "f6827a8c796a10c2",
        "value": 0.155,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>8.9%</td><td>11.5%</td><td>12.1%</td><td>18.1%</td><td>13.8%</td><td>17.0%</td><td>14.0%</td><td>15.5%</td><td>15.5%</td><td>15.0%</td></tr><tr><td>% growth</td><td>29%</td><td>46%</td><td>10%</td>",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "61bc8dfff939fb2e",
        "value": 0.155,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>11.5%</td><td>12.1%</td><td>18.1%</td><td>13.8%</td><td>17.0%</td><td>14.0%</td><td>15.5%</td><td>15.5%</td><td>15.0%</td></tr><tr><td>% growth</td><td>29%</td><td>46%</td><td>10%</td><td>16%</td><t",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "bfcebec693daf376",
        "value": 0.15,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>12.1%</td><td>18.1%</td><td>13.8%</td><td>17.0%</td><td>14.0%</td><td>15.5%</td><td>15.5%</td><td>15.0%</td></tr><tr><td>% growth</td><td>29%</td><td>46%</td><td>10%</td><td>16%</td><td>14%</td><td>",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "a7677957d9df7c5f",
        "value": 0.2,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "s and BPH. Downside risks to our price target include adverse impacts from the recently implemented 20% tariff on the EU, adverse reimbursement decisions, regulatory delays, competition, and macro hea",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "1663c58637039902",
        "value": 0.15,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "loss. Stocks having 120 day volatility in the bottom quartile of S&P stocks will continue to have a 15% stop loss, and the remainder will have a 20% stop. Franchise Picks are not intended to represent",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "e86ef785188615a7",
        "value": 0.2,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "bottom quartile of S&P stocks will continue to have a 15% stop loss, and the remainder will have a 20% stop. Franchise Picks are not intended to represent a recommended portfolio of stocks and is not ",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "bf47c7245ed2cc9a",
        "value": 0.6069,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>Count</td><td>Percent</td><td>Count</td><td>Percent</td></tr><tr><td>BUY</td><td>2112</td><td>60.69%</td><td>367</td><td>17.38%</td><td>117</td><td>5.54%</td></tr><tr><td>HOLD</td><td>1211</td><",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "857323d5b9350f61",
        "value": 0.17379999999999998,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>Count</td><td>Percent</td></tr><tr><td>BUY</td><td>2112</td><td>60.69%</td><td>367</td><td>17.38%</td><td>117</td><td>5.54%</td></tr><tr><td>HOLD</td><td>1211</td><td>34.80%</td><td>105</td><",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "f016db8ff2104be8",
        "value": 0.0554,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ent</td></tr><tr><td>BUY</td><td>2112</td><td>60.69%</td><td>367</td><td>17.38%</td><td>117</td><td>5.54%</td></tr><tr><td>HOLD</td><td>1211</td><td>34.80%</td><td>105</td><td>8.67%</td><td>22</td><td",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "470c1314dd5b3622",
        "value": 0.348,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "69%</td><td>367</td><td>17.38%</td><td>117</td><td>5.54%</td></tr><tr><td>HOLD</td><td>1211</td><td>34.80%</td><td>105</td><td>8.67%</td><td>22</td><td>1.82%</td></tr><tr><td>UNDERPERFORM</td><td>157<",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "32e01cbef61ff972",
        "value": 0.0867,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "38%</td><td>117</td><td>5.54%</td></tr><tr><td>HOLD</td><td>1211</td><td>34.80%</td><td>105</td><td>8.67%</td><td>22</td><td>1.82%</td></tr><tr><td>UNDERPERFORM</td><td>157</td><td>4.51%</td><td>3</td",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "19bd5838b451f8f0",
        "value": 0.0182,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ".54%</td></tr><tr><td>HOLD</td><td>1211</td><td>34.80%</td><td>105</td><td>8.67%</td><td>22</td><td>1.82%</td></tr><tr><td>UNDERPERFORM</td><td>157</td><td>4.51%</td><td>3</td><td>1.91%</td><td>3</td>",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "c954837a74bcf9eb",
        "value": 0.0451,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>105</td><td>8.67%</td><td>22</td><td>1.82%</td></tr><tr><td>UNDERPERFORM</td><td>157</td><td>4.51%</td><td>3</td><td>1.91%</td><td>3</td><td>1.91%</td></tr></table><｜end▁of▁sentence｜>",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "c8eead7cf7cfd486",
        "value": 0.0191,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>22</td><td>1.82%</td></tr><tr><td>UNDERPERFORM</td><td>157</td><td>4.51%</td><td>3</td><td>1.91%</td><td>3</td><td>1.91%</td></tr></table><｜end▁of▁sentence｜>",
        "provenance": {
          "page": 6
        }
      },
      {
        "num_id": "278cac2175b2c5d3",
        "value": 0.0191,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "%</td></tr><tr><td>UNDERPERFORM</td><td>157</td><td>4.51%</td><td>3</td><td>1.91%</td><td>3</td><td>1.91%</td></tr></table><｜end▁of▁sentence｜>",
        "provenance": {
          "page": 6
        }
      }
    ],
    "claims": [],
    "relations": [],
    "extraction_summary": {
      "figures_count": 6,
      "tables_count": 0,
      "numerical_data_count": 144,
      "passages_count": 79,
      "entities_count": 20
    }
  }
}